![FDA Advisory No.2021-0723 || Public Health Warning Against the Continuous Selling of the Unregistered Drug Product Lianhua Qingwen Jiaonang with Chinese Characters - Food and Drug Administration FDA Advisory No.2021-0723 || Public Health Warning Against the Continuous Selling of the Unregistered Drug Product Lianhua Qingwen Jiaonang with Chinese Characters - Food and Drug Administration](https://www.fda.gov.ph/wp-content/uploads/2021/04/FDA-Advisory-No.2021-0723.png)
FDA Advisory No.2021-0723 || Public Health Warning Against the Continuous Selling of the Unregistered Drug Product Lianhua Qingwen Jiaonang with Chinese Characters - Food and Drug Administration
![FDA Advisory No.2022-1612-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na “Lianhua Qingwen Capsules 24's” 1. - Food and Drug Administration FDA Advisory No.2022-1612-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na “Lianhua Qingwen Capsules 24's” 1. - Food and Drug Administration](https://www.fda.gov.ph/wp-content/uploads/2022/09/FDA-Advisory-No.2022-1612-A.png)
FDA Advisory No.2022-1612-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na “Lianhua Qingwen Capsules 24's” 1. - Food and Drug Administration
![Frontiers | Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China Frontiers | Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China](https://www.frontiersin.org/files/MyHome%20Article%20Library/560114/560114_Thumb_400.jpg)
Frontiers | Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China
![Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects - ScienceDirect Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332220308349-gr1.jpg)
Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects - ScienceDirect
![FDA Advisory No. 2020-767 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product OTC Lianhua Qingwen Jiaonang - Food and Drug Administration FDA Advisory No. 2020-767 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product OTC Lianhua Qingwen Jiaonang - Food and Drug Administration](https://www.fda.gov.ph/wp-content/uploads/2021/02/FDA-Advisory-No.2020-767.jpg)